Peptide nucleic acid (PNA) binding-mediated induction of human γ-globin gene expression

Gan Wang, Xiaoxin Xu, Betty Sue Pace, David A. Dean, Peter M. Glazer, Phillip Chan, Steven R. Goodman, Inna Shokolenko

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Peptide nucleic acids (PNAs) can bind to homopurine/homopyrimidine sequences of double-stranded DNA targets in a sequence-specific manner and form [PNA]2/DNA triplexes with single-stranded DNA D-loop structures at the PNA binding sites. These D-loop structures have been found to have a capacity to initiate transcription in vitro. If this strategy can be used to induce transcription of endogenous genes, it may provide a novel approach for gene therapy of many human diseases. Human β globin disorders such as sickle cell anemia and β-thalassemia are very common genetic diseases that are caused by mutations in the β-globin gene. When γ-globin genes are highly expressed in sickle cell patients, the presence of high levels of fetal hemoglobin (HbF, α2γ2) can compensate for the defective β-globin gene product and such patients have much improved symptoms or are free of disease. However, the γ-globin genes are developmentally regulated and normally expressed at very low levels (> 1%) in adult blood cells. We have investigated the possibility of inducing γ-globin gene expression with PNAs. Using PNAs designed to bind to the 5' flanking region of the γ-globin gene, induction of expression of a reporter gene construct was demonstrated both in vitro and in vivo. More importantly, PNA-mediated induction of endogenous γ-globin gene expression was also demonstrated in K562 human erythroleukemia cells. This result suggests that induction of γ-globin gene expression with PNAs might provide a new approach for the treatment of sickle cell disease. PNA-induced gene expression strategy also may have implications in gene therapy of other diseases such as genetic diseases, cancer and infectious diseases.

Original languageEnglish (US)
Pages (from-to)2806-2813
Number of pages8
JournalNucleic Acids Research
Volume27
Issue number13
DOIs
StatePublished - Jul 1 1999

Fingerprint

Peptide Nucleic Acids
Globins
Gene Expression
Inborn Genetic Diseases
Genes
Sickle Cell Anemia
Genetic Therapy
Fetal Hemoglobin
Leukemia, Erythroblastic, Acute
Thalassemia
5' Flanking Region
Single-Stranded DNA
Reporter Genes
Communicable Diseases
Blood Cells
Binding Sites

ASJC Scopus subject areas

  • Genetics

Cite this

Peptide nucleic acid (PNA) binding-mediated induction of human γ-globin gene expression. / Wang, Gan; Xu, Xiaoxin; Pace, Betty Sue; Dean, David A.; Glazer, Peter M.; Chan, Phillip; Goodman, Steven R.; Shokolenko, Inna.

In: Nucleic Acids Research, Vol. 27, No. 13, 01.07.1999, p. 2806-2813.

Research output: Contribution to journalArticle

Wang, G, Xu, X, Pace, BS, Dean, DA, Glazer, PM, Chan, P, Goodman, SR & Shokolenko, I 1999, 'Peptide nucleic acid (PNA) binding-mediated induction of human γ-globin gene expression', Nucleic Acids Research, vol. 27, no. 13, pp. 2806-2813. https://doi.org/10.1093/nar/27.13.2806
Wang, Gan ; Xu, Xiaoxin ; Pace, Betty Sue ; Dean, David A. ; Glazer, Peter M. ; Chan, Phillip ; Goodman, Steven R. ; Shokolenko, Inna. / Peptide nucleic acid (PNA) binding-mediated induction of human γ-globin gene expression. In: Nucleic Acids Research. 1999 ; Vol. 27, No. 13. pp. 2806-2813.
@article{bb29848076c347c19ff4e25ae69567de,
title = "Peptide nucleic acid (PNA) binding-mediated induction of human γ-globin gene expression",
abstract = "Peptide nucleic acids (PNAs) can bind to homopurine/homopyrimidine sequences of double-stranded DNA targets in a sequence-specific manner and form [PNA]2/DNA triplexes with single-stranded DNA D-loop structures at the PNA binding sites. These D-loop structures have been found to have a capacity to initiate transcription in vitro. If this strategy can be used to induce transcription of endogenous genes, it may provide a novel approach for gene therapy of many human diseases. Human β globin disorders such as sickle cell anemia and β-thalassemia are very common genetic diseases that are caused by mutations in the β-globin gene. When γ-globin genes are highly expressed in sickle cell patients, the presence of high levels of fetal hemoglobin (HbF, α2γ2) can compensate for the defective β-globin gene product and such patients have much improved symptoms or are free of disease. However, the γ-globin genes are developmentally regulated and normally expressed at very low levels (> 1{\%}) in adult blood cells. We have investigated the possibility of inducing γ-globin gene expression with PNAs. Using PNAs designed to bind to the 5' flanking region of the γ-globin gene, induction of expression of a reporter gene construct was demonstrated both in vitro and in vivo. More importantly, PNA-mediated induction of endogenous γ-globin gene expression was also demonstrated in K562 human erythroleukemia cells. This result suggests that induction of γ-globin gene expression with PNAs might provide a new approach for the treatment of sickle cell disease. PNA-induced gene expression strategy also may have implications in gene therapy of other diseases such as genetic diseases, cancer and infectious diseases.",
author = "Gan Wang and Xiaoxin Xu and Pace, {Betty Sue} and Dean, {David A.} and Glazer, {Peter M.} and Phillip Chan and Goodman, {Steven R.} and Inna Shokolenko",
year = "1999",
month = "7",
day = "1",
doi = "10.1093/nar/27.13.2806",
language = "English (US)",
volume = "27",
pages = "2806--2813",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - Peptide nucleic acid (PNA) binding-mediated induction of human γ-globin gene expression

AU - Wang, Gan

AU - Xu, Xiaoxin

AU - Pace, Betty Sue

AU - Dean, David A.

AU - Glazer, Peter M.

AU - Chan, Phillip

AU - Goodman, Steven R.

AU - Shokolenko, Inna

PY - 1999/7/1

Y1 - 1999/7/1

N2 - Peptide nucleic acids (PNAs) can bind to homopurine/homopyrimidine sequences of double-stranded DNA targets in a sequence-specific manner and form [PNA]2/DNA triplexes with single-stranded DNA D-loop structures at the PNA binding sites. These D-loop structures have been found to have a capacity to initiate transcription in vitro. If this strategy can be used to induce transcription of endogenous genes, it may provide a novel approach for gene therapy of many human diseases. Human β globin disorders such as sickle cell anemia and β-thalassemia are very common genetic diseases that are caused by mutations in the β-globin gene. When γ-globin genes are highly expressed in sickle cell patients, the presence of high levels of fetal hemoglobin (HbF, α2γ2) can compensate for the defective β-globin gene product and such patients have much improved symptoms or are free of disease. However, the γ-globin genes are developmentally regulated and normally expressed at very low levels (> 1%) in adult blood cells. We have investigated the possibility of inducing γ-globin gene expression with PNAs. Using PNAs designed to bind to the 5' flanking region of the γ-globin gene, induction of expression of a reporter gene construct was demonstrated both in vitro and in vivo. More importantly, PNA-mediated induction of endogenous γ-globin gene expression was also demonstrated in K562 human erythroleukemia cells. This result suggests that induction of γ-globin gene expression with PNAs might provide a new approach for the treatment of sickle cell disease. PNA-induced gene expression strategy also may have implications in gene therapy of other diseases such as genetic diseases, cancer and infectious diseases.

AB - Peptide nucleic acids (PNAs) can bind to homopurine/homopyrimidine sequences of double-stranded DNA targets in a sequence-specific manner and form [PNA]2/DNA triplexes with single-stranded DNA D-loop structures at the PNA binding sites. These D-loop structures have been found to have a capacity to initiate transcription in vitro. If this strategy can be used to induce transcription of endogenous genes, it may provide a novel approach for gene therapy of many human diseases. Human β globin disorders such as sickle cell anemia and β-thalassemia are very common genetic diseases that are caused by mutations in the β-globin gene. When γ-globin genes are highly expressed in sickle cell patients, the presence of high levels of fetal hemoglobin (HbF, α2γ2) can compensate for the defective β-globin gene product and such patients have much improved symptoms or are free of disease. However, the γ-globin genes are developmentally regulated and normally expressed at very low levels (> 1%) in adult blood cells. We have investigated the possibility of inducing γ-globin gene expression with PNAs. Using PNAs designed to bind to the 5' flanking region of the γ-globin gene, induction of expression of a reporter gene construct was demonstrated both in vitro and in vivo. More importantly, PNA-mediated induction of endogenous γ-globin gene expression was also demonstrated in K562 human erythroleukemia cells. This result suggests that induction of γ-globin gene expression with PNAs might provide a new approach for the treatment of sickle cell disease. PNA-induced gene expression strategy also may have implications in gene therapy of other diseases such as genetic diseases, cancer and infectious diseases.

UR - http://www.scopus.com/inward/record.url?scp=0033168095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033168095&partnerID=8YFLogxK

U2 - 10.1093/nar/27.13.2806

DO - 10.1093/nar/27.13.2806

M3 - Article

VL - 27

SP - 2806

EP - 2813

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 13

ER -